GlaxoSmithKline wins Benlysta US label expansion for children
The approval marks the first medicine in the US approved for children with systemic lupus erythematosus.
Read More
Tag: PLUTO
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
